Zolmitriptan is a selective serotonin receptor agonist of the 1B and 1D subtypes. It is a triptan used in the acute treatment of migraine attacks with or without aura and cluster headaches.Zolmitriptan is marketed by AstraZeneca with the brand names Zomig Zomigon (Argentina Canada & Greece) AscoTop (Germany) and Zomigoro (France). In 2008 Zomig generated nearly $154 million in sales.AstraZeneca’s U.S.
This page contains content from the copyrighted Wikipedia article "Zolmitriptan"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
